Minimally invasive surgery is one of the current methods of cancer treatment, but in China's cancer patients, the number of people using minimally invasive surgery has not exceeded 10%. The reason is the limitation of the performance of medical devices in minimally invasive surgery, which makes many special patients can only make painful choices between life and quality of life. With the slogan of "mass entrepreneurship, innovation", China has always been a breakthrough in the innovation of the development of domestic medical equipment. Shanghai Yisi Medical Technology Co., Ltd., a company specializing in minimally invasive surgical instruments, has completed the historical mission of China's general medical devices from scratch in less than 10 years through imitation and imitation development methods, especially In the field of low-end medical devices, the company's medical devices have occupied more than 60% of the domestic market share, and created three techniques for single-handed operation of the endoscopic stapler, changing the rotation angle of the surgical instrument, and curved titanium nail forming technology. Innovation has become a leader in the field of medical devices in China. Nie Honglin, the founder of the company, believes that in order to break the embarrassing situation that high-end medical devices are basically monopolized by foreign products, it is necessary to integrate the discovery and innovation wisdom of surgical experts in the clinical field, and domestic medical devices can better participate in global competition. Therefore, first-line clinical surgeons, related research institutes, medical journals, and self-owned research and development teams form the innovative think tank of Shanghai Yisi. “Clinical experts are the first signers of product patents, and they are involved in profit sharing after industrialization of scientific research results.†Nie Honglin said that Yisi Medical Think Tank has designed a variety of profit-sharing models, and clinicians are free to choose to transfer intellectual property rights or hold Shares, allowing doctors to obtain the corresponding economic value, is an important guarantee to encourage the continued prosperity of technological innovation in China's medical device industry. Rectal cancer is located at the bottom of the pelvis and is located in a narrow position, which is a difficult location for surgical instruments. At present, the internationally accepted endoscopic stapler is 42 rotations, and some patients with low rectal cancer often cannot be completely removed. Therefore, in order to save their lives, some patients have to remove the entire anus from the tumor. After continuous trials, there is a new consensus on the interaction between the Yisi technical team and the clinician – as long as the angle of the endoscope is increased to 60, the clinical needs can be fully met. As a result, the company first solved the problem by creating a 60-bend angled endoscope stapler. YT-H711 YT-H711 Shenzhen Sunshine Technology Co.,Ltd , https://www.yatwin.com